Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
24°
Site search
Search
Menu
Subscribe
Home
News
Local News
Sports
Obituaries
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Explore the Sheyenne
Archives
Best of 2024
Calendar Photos
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about INCY
Recent news which mentions INCY
< Previous
1
2
3
4
5
6
7
8
9
Next >
Incyte's Topical JAK Inhibitor Scores FDA Approval For Atopic Dermatitis
September 22, 2021
Tickers
INCY
Tags
Market News
Health Care
Trading Ideas
From
Benzinga
The Daily Biotech Pulse: Aprea Jumps On ESMO Presentation, Verrica Sinks On Regulatory Setback, Aerie CEO Quits, J&J Touts Positive COVID-19 Booster Shot Data
September 21, 2021
Tickers
ABSI
ADTX
AERI
AFIB
Tags
NPCE
DRMA
Biotech
From
Benzinga
Incyte's Pemazyre Wins Conditional Approval For Bile Duct Cancer In Canada
September 20, 2021
Tickers
INCY
Tags
Market News
FDA
General
From
Benzinga
Is AbbVie a Bad News Buy?
September 19, 2021
Tickers
ABBV
INCY
LLY
PFE
Tags
LLY
ABBV
INCY
From
Motley Fool
The Week Ahead In Biotech (Sept. 19-25): Incyte, Verrica FDA Decisions And Conference Presentations In The Spotlight
September 19, 2021
Tickers
AGTC
APRE
BMY
BNTX
Tags
ZLAB
SRPT
HLTH
From
Benzinga
Price Over Earnings Overview: Incyte
September 14, 2021
Tickers
INCY
Tags
News
Intraday Update
Benzinga
From
Benzinga
FDA Hits JAK inhibitors With Heart Safety, Cancer Warnings: All You Need To Know
September 02, 2021
Tickers
ABBV
BMY
INCY
LLY
Tags
FDA
BMY
General
From
Benzinga
Attention Biotech Investors: Mark Your Calendar For September PDUFA Dates
August 31, 2021
Tickers
ABBV
ASND
BGNE
BIIB
Tags
RHHBY
BIIB
ASND
From
Benzinga
If you’ve got the stock market jitters, here are 20 companies in two defensive sectors
August 30, 2021
Tickers
ABC
AES
ANTM
BAX
Tags
MCK
HUM
TFX
From
MarketWatch
The Daily Biotech Pulse: MorphoSys-Incyte Snag European Nod, Immutep Granted Chinese Patent, Bolt Biotherapeutics Strike Oncology Collaboration
August 27, 2021
Tickers
AGEN
ALKS
ALZN
BLFS
Tags
IMMP
TCRX
ALZN
From
Benzinga
Incyte - MorphoSys's Diffuse Large B-Cell Lymphoma Drug Wins European Approval
August 27, 2021
Tickers
INCY
MOR
Tags
Market News
Health Care
INCY
From
Benzinga
These 20 ‘left behind’ stocks among the S&P 500 are expected to rise up to 59% over 12 months
August 26, 2021
Tickers
AAPL
AMZN
ATVI
BAX
Tags
ZBH
MSFT
SPY
From
MarketWatch
BriaCell, ImaginAb Join Forces To Assess Imaging Tech In Breast Cancer Trial
August 19, 2021
Tickers
BCTX
INCY
Tags
Biotech
Movers
Benzinga
From
Benzinga
The Daily Biotech Pulse: Lilly Reorganizes Business Units In Neuroscience Focus, Helius Medical Spikes On Breakthrough Designation, Ra Medical Sells Dermatology Business
August 17, 2021
Tickers
ABSI
ABVC
ACAD
ACHV
Tags
ENSC
EVFM
NKTR
From
Benzinga
Incyte Out Licenses Lymphoma Drug To InnoCare In Greater China
August 17, 2021
Tickers
INCY
MOR
XNCR
Tags
XNCR
General
Small Cap
From
Benzinga
BriaCell Therapeutics Attacks Cancer with Novel Off-the-Shelf Immunotherapies
August 16, 2021
Tickers
INCY
Tags
General
Partner Content
Market News
From
Benzinga
The Daily Biotech Pulse: Moderna's Vaccine Produces Durable Response Against Variants, FDA Approves Jazz's Sleep Disorder Drug, Dermata IPO
August 13, 2021
Tickers
ABVC
ACAD
ACHL
ADGI
Tags
MBRX
HOOK
INVA
From
Benzinga
The Daily Biotech Pulse: Xeris Gets OK For Initiating Hyperthyroidism Study, Merck-Eisai Snag FDA Approval For Drug Combo, Decision Day For Jazz Pharma
August 12, 2021
Tickers
ABCL
ACET
ACHV
ADGI
Tags
ARNA
DTIL
SYBX
From
Benzinga
The Daily Biotech Pulse: FDA Rejects FibroGen's Anemia Drug, Crinetics Gains On Positive Readout, BioCryst Withdraws Public Offering
August 11, 2021
Tickers
ACAD
ACHV
ADMA
AKRO
Tags
RANI
NAVB
HOOK
From
Benzinga
Stocks That Hit 52-Week Lows On Tuesday
August 10, 2021
Tickers
ACAD
AKRO
APEI
ARNA
Tags
DNAD
NSH
52/Week Lows
From
Benzinga
The Daily Biotech Pulse: Arcturus Soars On COVID-19 Vaccine Updates, Merck's Keytruda On Track For More Label Expansions, Eliem Debuts
August 10, 2021
Tickers
ACET
ADGI
AKRO
AKYA
Tags
BLFS
AXSM
KMPH
From
Benzinga
Is the PD-(L)1 Party Over After Incyte's FDA Rejection?
August 07, 2021
Tickers
BMY
INCY
L
MRK
Tags
INCY
Market News
BMY
From
Motley Fool
Incyte Corporation (INCY) Q2 2021 Earnings Call Transcript
August 03, 2021
Tickers
INCY
Tags
Market News
INCY
From
Motley Fool
Attention Biotech Investors: Mark Your Calendar For August PDUFA Dates
August 02, 2021
Tickers
ALBO
AXSM
CARA
CCXI
Tags
PFE
Benzinga
Biotech
From
Benzinga
A Preview Of Incyte's Earnings
August 02, 2021
Tickers
INCY
Tags
BZI/EP
INCY
Earnings
From
Benzinga
Videogames entered the mainstream in the pandemic, but the industry faces a rough transition
August 01, 2021
Tickers
AAPL
ABC
ABMD
AEE
Tags
MAR
EXPD
UNM
From
MarketWatch
2 Stocks Under $100 You Can Buy and Hold Forever
July 31, 2021
Tickers
AMZN
AZN
INCY
Tags
INCY
Market News
AZN
From
Motley Fool
Eli Lilly-Incyte's Rheumatoid Arthritis Drug Gets OK From FDA For Solo Use In Hospitalized COVID-19 Patients
July 29, 2021
Tickers
GILD
INCY
LLY
Tags
Briefs
News
Biotech
From
Benzinga
7 Cheap Value Stocks to Buy for August 2021
July 27, 2021
Tickers
AMZN
BRK-A
BRK-B
CVS
Tags
BRK/B
Market News
FCX
From
InvestorPlace
FDA Strikes Off Incyte's Retifanlimab Application In Anal Cancer
July 26, 2021
Tickers
INCY
Tags
Biotech
INCY
Benzinga
From
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.